Using a Fan With Aromatherapy in Breathlessness Patients in Terminal Illness

Not Applicable

• Conditions: Terminal Illness; Breathlessness; Aromatherapy; Fans
• Interventions: Behavioral: Blow a fan to the face combine aromatherapy; Behavioral: Blow a fan to the feet; Behavioral: Blow a fan to the face

• Registration Number: NCT05625854
• Lead Sponsor: Tsai-Wei Huang

Brief Summary

Difficulty breathing is a very devastating symptom, often seen in terminal patients. Accompanied by physical, psychological, emotional, and social limitations, Not to mention the ambiguity in the occurrence of dyspnea symptoms and the difficulty in obtaining satisfactory quality of symptom care. The purpose of this study is to confirm the use of non-drug interventions in clinical situations, such as fans and aromatherapy to alleviate the complications of end-stage patients. The effectiveness of the symptoms of dyspnea.

Detailed Description

Difficulty breathing is a very devastating symptom, often seen in terminal patients. Accompanied by physical, psychological, emotional, and social limitations, Not to mention the ambiguity in the occurrence of dyspnea symptoms and the difficulty in obtaining satisfactory quality of symptom care. The purpose of this study is to confirm the use of non-drug interventions in clinical situations, such as fans and aromatherapy to alleviate the complications of end-stage patients. The effectiveness of the symptoms of dyspnea.

Inclusion criteria

1. Over 20 years old.

2. It is determined by the physician to meet the final diagnosis conditions.

3. Symptoms of dyspnea.

4. The daily physical status of patients is assessed using the East Coast Cancer Clinical Research Cooperative Organization Assessment Scale (Eastern Cooperative Oncology Group, ECOG) ≧ 2 points.

5. Able to communicate in Mandarin or Taiwanese or written conversation.

6. Unconscious disorder.

7. After explaining and explaining, agree to participate in this research and sign the consent form.

Exclusion criteria

1. Receive treatment for facial trigeminal nerve damage.

2. Abnormal sense of smell.

Study Timeline

• Study First Submitted: 2021-09-14
• Status Verified: 2022-11
• Study First Submitted QC: 2022-11-22
• Last Update Submitted: 2022-11-22
• Study First Posted: 2022-11-23
• Last Update Posted: 2022-11-23
• Study Start: 2022-11-25
• Primary Completion: 2024-12-31
• Study Completion: 2024-12-31

Recruitment & Eligibility

• Status: ENROLLING_BY_INVITATION
• Sex: All
• Target Recruitment: 99

Inclusion Criteria

1. Over 20 years old.
2. It is determined by the physician to meet the final diagnosis conditions.
3. Symptoms of dyspnea.
4. The status of patients is assessed using the East Coast Cancer Clinical Research Cooperative Organization Assessment Scale (ECOG) ≧ 2 points.
5. Able to communicate in Mandarin or Taiwanese or written conversation.
6. Conscience clear.
7. After explaining and explaining, agree to participate in this research and sign the consent form.

Exclusion Criteria

1. Receive treatment for facial trigeminal nerve damage.
2. Abnormal sense of smell.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Blow a fan to the face combine aromatherapy	Blow a fan to the face combine aromatherapy	-
Blow a fan to the feet	Blow a fan to the feet	-
Blow a fan to the face	Blow a fan to the face	-

Primary Outcome Measures

Name	Time	Method
Chinese version of the Respiratory Distress Observation Scale，C-RDOS	The score change up to three days.	RDOS is an eight-item ordinal scale designed to measure the presence and intensity of respiratory distress in adults. High score means high respiratory distress.

Secondary Outcome Measures

Name	Time	Method
Chinese version of the Edmonton Symptom Assessment System，C-ESAS	The score change up to three days.	The ESAS includes 11 symptoms: pain, tiredness, nausea, depression, anxiety, drowsiness, appetite, sleep, well-being, shortness of breath, and other. It uses a 0-10 numerical scale: 0 shows the absence of a symptom, and 10 shows the worst experience of the symptom.
Smart bracelet_Heart rate variability (HRV)	Continue wear bracelet five days to record HRV data.	HRV is the physiological phenomenon of the variation in the time interval between consecutive heartbeats in milliseconds. A normal, healthy heart does not tick evenly like a metronome, but instead, when looking at the milliseconds between heartbeats, there is constant variation.
Patient Health Questionnaire (PHQ-9)	The score change up to three days.	The PHQ-9 is the depression module, which scores each of the nine DSM-IV criteria as "0" (not at all) to "3" (nearly every day). It has been validated for use in primary care.\[2\]; It is not a screening tool for depression but it is used to monitor the severity of depression and response to treatment. high score mean higher emotion distress.

Trial Locations

Locations (1)

Taipei Medical University; 🇨🇳 Taipei, Taiwan